Patents by Inventor Giovanni Salvatori

Giovanni Salvatori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAMENT FOR THE TREATMENT OF FUNGAL INFECTIONS PARTICULARLY ASPERGILLOSIS
    Publication number: 20140296135
    Abstract: The combination of pentraxin PTX3 with antifungals is described for the treatment of fungal infections and particularly for infections caused by Aspergillus fumigatus.
    Type: Application
    Filed: June 4, 2014
    Publication date: October 2, 2014
    Inventors: Giovanni Salvatori, Paolo Carminati, Luigina Romani
  • Medicament for the treatment of fungal infections particularly aspergillosis
    Patent number: 8778389
    Abstract: The combination of pentraxin PTX3 with antifungal agents is described for the treatment of fungal infections and particularly for infections caused by Aspergillus fumigatus. Thanks to the synergistic effect of the two drugs, the combination allows the administration of suboptimal doses of antifungal agent.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: July 15, 2014
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Paolo Carminati, Giovanni Salvatori, Romani Luigina
  • Deglycosylated and desialidated long pentraxin PTX3
    Patent number: 7833981
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: November 16, 2010
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Rita De Santis, Giovanni Salvatori, Paolo Carminati, Antonio Inforzato
  • DEGLYCOSYLATED AND DESIALIDATED LONG PENTRAXIN PTX3
    Publication number: 20100209442
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Application
    Filed: February 23, 2010
    Publication date: August 19, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Paolo Carminati, Rita De Santis, Antonio Inforzato, Giovanni Salvatori
  • Deglycosylated and desialidated long pentraxin PTX3
    Patent number: 7683032
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: March 23, 2010
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Paolo Carminati, Rita De Santis, Antonio Inforzato, Giovanni Salvatori
  • Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
    Patent number: 7629003
    Abstract: Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds. New esters of L-carnitine and alkanoyl L-carnitines of formula (I) are also disclosed wherein the R groups are as defined in the description.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: December 8, 2009
    Assignee: Sigma-Tau Farmaceutiche Riunite S.p.A.
    Inventors: Claudio Pisano, Maria Ornella Tinti, Mosé Santaniello, Luciana Critelli, Giovanni Salvatori
  • Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
    Patent number: 7585519
    Abstract: Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds. New esters of L-carnitine and alkanoyl L-carnitines of formula (I) are also disclosed wherein the R groups are as defined in the description.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: September 8, 2009
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Claudio Pisano, Maria Ornella Tinti, Mosé Santaniello, Luciana Critelli, Giovanni Salvatori
  • Medicament for the Treatment of Fungal Infections Particularly Aspergillosis
    Publication number: 20080026997
    Abstract: The combination of pentraxin PTX3 with antifungal agents is described for the treatment of fungal infections and particularly for infections caused by Aspergillus fumigatus. Thanks to the synergistic effect of the two drugs, the combination allows the administration of suboptimal doses of antifungal agent.
    Type: Application
    Filed: April 28, 2005
    Publication date: January 31, 2008
    Inventors: Paolo Carminati, Giovanni Salvatori, Romani Luigina
  • Deglycosylated and Desialidated Long Pentraxin Ptx3
    Publication number: 20070249021
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Application
    Filed: September 28, 2005
    Publication date: October 25, 2007
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Paolo Carminati, Rita De Santis, Antonio Inforzato, Giovanni Salvatori
  • Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
    Publication number: 20070190128
    Abstract: Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds. New esters of L-carnitine and alkanoyl L-carnitines of formula (I) are also disclosed wherein the R groups are as defined in the description.
    Type: Application
    Filed: March 27, 2007
    Publication date: August 16, 2007
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Claudio Pisano, Maria Tinti, Mose Santaniello, Luciana Critelli, Giovanni Salvatori
  • Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
    Publication number: 20050079209
    Abstract: Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds. New esters of L-carnitine and alkanoyl L-carnitines of formula (I) are also disclosed wherein the R groups are as defined in the description.
    Type: Application
    Filed: July 23, 2003
    Publication date: April 14, 2005
    Inventors: Claudio Pisano, Maria Tinti, Mose Santaniello, Luciana Critelli, Giovanni Salvatori
  • Esters of I-carnitine or alkanoyl I-carnitines
    Patent number: 6797281
    Abstract: Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds. New esters of L-carnitine and alkanoyl L-carnitines of formula (I) are also disclosed wherein the R groups are as defined in the description.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: September 28, 2004
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Claudio Pisano, Maria Ornella Tinti, Mosé Santaniello, Luciana Critelli, Giovanni Salvatori
  • Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
    Publication number: 20040186175
    Abstract: Esters of L-carnitine and alkanoyl L-carnitines are described which can be used as cationic lipids for the intracellular delivery of pharmacologically active compounds. New esters of L-carnitine and alkanoyl L-carnitines of formula (I) are also disclosed wherein the R groups are as defined in the description.
    Type: Application
    Filed: January 28, 2004
    Publication date: September 23, 2004
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Claudio Pisano, Maria Ornella Tinti, Mose Santaniello, Luciana Critelli, Giovanni Salvatori